Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #38,401 to #38,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The EKG in the patient treated with adenosine (2 revisions)
  2. The EKG in the patient treated with amiodarone (2 revisions)
  3. The EKG in the patient treated with beta blockers (2 revisions)
  4. The EKG in the patient treated with bretylium (2 revisions)
  5. The EKG in the patient treated with calcium channel blockers (2 revisions)
  6. The EKG in the patient treated with digitalis (2 revisions)
  7. The EKG in the patient treated with disopyramide (2 revisions)
  8. The EKG in the patient treated with lidocaine (2 revisions)
  9. The EKG in the patient treated with lithium (2 revisions)
  10. The EKG in the patient treated with phenothiazines (2 revisions)
  11. The EKG in the patient treated with phenytoin (2 revisions)
  12. The EKG in the patient treated with procainamide (2 revisions)
  13. The EKG in the patient treated with quinidine (2 revisions)
  14. The EKG in the patient treated with tocainide (2 revisions)
  15. The EKG of cardiac transplantation (2 revisions)
  16. The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients (2 revisions)
  17. The Global Fund to Fight AIDS, Tuberculosis and Malaria (2 revisions)
  18. The Heart in Insulin Dependent Diabetes Mellitus (2 revisions)
  19. The Heart in Köhlmeier-Degos Disease (2 revisions)
  20. The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS III Guidelines (2 revisions)
  21. The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  22. The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  23. The Living Guidelines: Maintenance of sinus rhythm: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  24. The Living Guidelines: Maintenance of sinus rhythm: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  25. The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS III Guidelines (2 revisions)
  26. The Living Guidelines: Patients with Pulmonary Hypertension: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  27. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS III Guidelines (2 revisions)
  28. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  29. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS IIb Guidelines (2 revisions)
  30. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): Suggest Revisions to the CLASS I Guidelines (2 revisions)
  31. The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS III Guidelines (2 revisions)
  32. The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  33. The Living Guidelines: Patients with acute myocardial infarction: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  34. The Living Guidelines: Patients with hyperthyroidism: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  35. The Living Guidelines: Patients with hypertrophic cardiomyopathy: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  36. The Living Guidelines: Patients with hypertrophic cardiomyopathy: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  37. The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  38. The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS IIb Guidelines (2 revisions)
  39. The Living Guidelines: Patients with postoperative atrial fibrillation: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  40. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS III Guidelines (2 revisions)
  41. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  42. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS IIb Guidelines (2 revisions)
  43. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS I Guidelines (2 revisions)
  44. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  45. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: Suggest Revisions to the CLASS IIb Guidelines (2 revisions)
  46. The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS III Guidelines (2 revisions)
  47. The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIa Guidelines (2 revisions)
  48. The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS IIb Guidelines (2 revisions)
  49. The Living Guidelines: Pharmacological rate control during atrial fibrillation Suggest Revisions to the CLASS I Guidelines (2 revisions)
  50. The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS IIb Guidelines (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"